Nathaniel Erskine-Smith at the Industry, Science and Technology Committee

On February 18th, 2021. See this statement in context.

February 18th, 2021 / 11:25 a.m.

Liberal

Nathaniel Erskine-Smith Liberal Beaches—East York, ON

Again, I'm certain there's a good answer, but why pursue with Novavax and not, say, AstraZeneca, where we know AstraZeneca is already now approved by the EU, by the WHO and by the U.K.? I expect Novavax will be successful; I hope it will be successful, but why not pursue through NRC, in the medium term, as you say, a proven vaccine?

See context to find out what was said next.